Identifying stakeholders’ perspective of smart inhalers and its implementation into the Dutch healthcare system: a qualitative study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON28455

Enrollment

Registered

2020-04-01

Start date

2020-04-06

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

2 focus groups (one with health care professionals and one with patients) and several interviews with regulators will be conducted.

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria patients: - Age = 18 years - Self-reported doctor-diagnosed asthma - Use of maintenance inhalation medication for asthma - Adequate oral fluency in Dutch - Willing and able to provide written informed consent

Exclusion criteria

Exclusion criteria: Exclusion criteria patients: Asthma patients only using quick-relief (rescue) medication

Design outcomes

Primary

Measure	Time frame
The recordings of the focus groups and interviews will be transcribed, coded and analyzed according to the consolidated criteria for reporting qualitative research (COREQ). The results will be used to formulate an implementation plan for smart inhalers into the Dutch healthcare system.	—

Contacts

Public ContactSusanne van de Hei

University Medical Center Groningen

s.j.van.de.hei@umcg.nl+31(0)50 2113898

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)